Search Results
You are looking at 1 - 1 of 1 items for
- Author: Maria Serova x
- Refine by access: All content x
Sorbonne Université, CNRS -Institut de Biologie Paris Seine (BIOSIPE), Paris, France
Search for other papers by René Lafont in
Google Scholar
PubMed
Search for other papers by Maria Serova in
Google Scholar
PubMed
Search for other papers by Blaise Didry-Barca in
Google Scholar
PubMed
Search for other papers by Sophie Raynal in
Google Scholar
PubMed
Search for other papers by Louis Guibout in
Google Scholar
PubMed
Search for other papers by Laurence Dinan in
Google Scholar
PubMed
Search for other papers by Stanislas Veillet in
Google Scholar
PubMed
Search for other papers by Mathilde Latil in
Google Scholar
PubMed
Search for other papers by Waly Dioh in
Google Scholar
PubMed
Search for other papers by Pierre J Dilda in
Google Scholar
PubMed
20-Hydroxyecdysone (20E) is a steroid hormone that plays a key role in insect development through nuclear ecdysteroid receptors (EcR/RXR complex) and at least one membrane GPCR receptor (DopEcR). It also displays numerous pharmacological effects in mammals, where its mechanism of action is still debated, involving either an unidentified GPCR or the estrogen ERβ receptor. The goal of this study was to better understand 20E mechanism of action in mammals. A mouse myoblast cell line (C2C12) and the gene expression of myostatin (a negative regulator of muscle growth) were used as a reporter system of anabolic activity. Experiments using protein-bound 20E established the involvement of a membrane receptor. 20E-like effects were also observed with angiotensin(1–7), the endogenous ligand of MAS. Additionally, the effect on myostatin gene expression was abolished by Mas receptor knock-down using siRNA or pharmacological inhibitors. 17β-Estradiol (E2) also inhibited myostatin gene expression, but protein-bound E2 was inactive, and E2 activity was not abolished by angiotensin(1–7) antagonists. A mechanism involving cooperation between the MAS receptor and a membrane-bound palmitoylated estrogen receptor is proposed. The possibility to activate the MAS receptor with a safe steroid molecule is consistent with the pleiotropic pharmacological effects of ecdysteroids in mammals and, indeed, the proposed mechanism may explain the close similarity between the effects of angiotensin(1–7) and 20E. Our findings open up many possible therapeutic developments involving stimulation of the protective arm of the renin–angiotensin–aldosterone system (RAAS) with 20E.
